Study on Molecular Mechanism of Latia Biohminescnece
拉蒂亚生物化学分子机制研究
基本信息
- 批准号:12045226
- 负责人:
- 金额:$ 8.06万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) Studies on substrate specificity using a series of analogs of the Latia luciferin suggested that the Latia luciferase recognized strrctly the 2,6,6-trimethylcyclohexene ring moiety in the luciferin structure. The corresponding enol acetate and benzoate analogs also possessed luciferin activities, indicating the formate moiety to be not essential for the Latia bioluminescence reaction. The rate of light production was delayed when the enol acetate analogue and benzoate analogue were used, indicating the hydrolysis step of the enol ester moiety at the active site of the luciferase may be rate determining step of the light production reaction. Interestingly, the corresponding 2,6-dimethylphenyl analogue also have luciferin activity Further studieson the relationship between structure and luciferin activity are currently under investigation.(2) Purification of Latia luciferase was achieved by a 5-step procedure including affinity chromatography on a Con A-supported column.(3 ) The purified luciferase exhibited a luciferin/luciferase reaction with the Latia luciferin without any cofactors such as "purple protein," previously reported as the cofactor, and gave the sarne bioluminescence spectra as those obtained with the crude luciferase containing "purple protein," indicating that the light emitter of Latia bioluminescence is a fluorophore present in the luciferase molecule.(4) The bioluminescent-active luciferase was found to have a molecular mass of 180 kDa and to be present as a hexamer of bioluminescent-inactive monomers having a molecular mass of 31 kDa. The Latia luciferase was found to be a glycoprotein. The glycoside moiety may be important for keeping the oligomeric structure and/or for bioluminescence reaction.(5) The c-DNA for Latia luciferase was cloned. The primary structure, deduced from the nucleotide sequence, consists of 294 amino acid residue in a single peptide chain with an N-glycosylated NSS sequence.
(1)利用一系列Latia荧光素类似物对底物专一性的研究表明,Latia荧光素酶能准确识别荧光素结构中的2,6,6-三甲基环己烯部分。相应的乙酸烯醇酯和苯甲酸类似物也具有荧光素活性,表明甲酸盐部分对Latia生物发光反应不是必需的。当使用乙酸烯醇酯类似物和苯甲酸酯类似物时,光产生速率被推迟,表明荧光素酶活性部位的烯醇酯部分的水解步骤可能是光产生反应的速率决定步骤。有趣的是,相应的2,6-二甲基苯基类似物也具有荧光素活性。关于结构和荧光素活性之间的关系的进一步研究目前正在进行中。(2)Latia荧光素酶的纯化是通过5步程序实现的,包括在ConA支撑的柱上进行亲和层析。(3)纯化的荧光素酶与Latia荧光素酶发生荧光素/荧光素酶反应,而没有任何辅助因素,如先前报道的辅因子“紫色蛋白”,并给出了与含有“紫色蛋白”的粗品荧光素酶相同的Sarne生物发光光谱,表明Latia生物发光的发光体是荧光素酶分子中存在的一个荧光团。(4)发现具有生物发光活性的荧光素酶的分子质量为180 kDa,并作为分子质量为31 kDa的生物发光不活跃单体的六角体存在。Latia荧光素酶是一种糖蛋白。糖苷部分对于保持低聚结构和/或生物发光反应可能是重要的。(5)克隆了Latia荧光素酶的c-DNA。根据核苷酸序列推导出的一级结构由294个氨基酸残基组成,在一个单肽链上带有N-糖基化的NSS序列。
项目成果
期刊论文数量(116)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Satoshi Kojima: "Improved Syntheses of Watasenia Preluciferin (Coelenterazine) and Watasenia Luciferin (Coelenterazine Disulfate), and Site Specific Syntheses of the Coelenterazine Monosulfates."ITE Letters on Batteries, New Technologies and Medicine. 2,N
Satoshi Kojima:“改进了 Watasenia 前荧光素(腔肠素)和 Watasenia 荧光素(腔肠素二硫酸盐)的合成,以及腔肠素单硫酸盐的位点特异性合成。”ITE 关于电池、新技术和医学的快报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shojiro Maki: "Effect of Solvent and Hydrogen during Selective Hydrogenation"Tetrahedron Lett.. 42,No.47. 8323-8327 (2001)
Shojiro Maki:“选择性氢化过程中溶剂和氢气的影响”Tetrahedron Lett.. 42,No.47。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shojiro Maki: "Development of Pd Black Deposited on Polypropylene Sheet as a Highly Selective Catalyst for Hydrogenation of Alkenes"Tetrahedron Lett.. 44,No.18. 3717-3721 (2003)
Shojiro Maki:“开发沉积在聚丙烯片上的钯黑作为烯烃氢化的高选择性催化剂”Tetrahedron Lett.. 44,第 18 期。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Maki: "Effect of Solvent and Hydrogen during Selective Hydrogenation"Tetrahedron Lett.. 42,No.47. 8323-8327 (2001)
S.Maki:“选择性氢化过程中溶剂和氢气的影响”Tetrahedron Lett.. 42,No.47。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mamoru Ohashi ら: "Differentiation Between N-Acetylchondrosine and N-Acetyldermosin by Matrix-assisted Laser Desorption Ionization Time-of-flight Post Source Decay Mass Spectrometry"J.Mass Spectrom.Jpn.. 48. 26-31 (2000)
Mamoru Ohashi 等:“通过基质辅助激光解吸电离飞行时间后源衰变质谱法区分 N-乙酰软骨素和 N-乙酰德莫辛”J.Mass Spectrom.Jpn.. 48. 26-31 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARUKI Niwa其他文献
HARUKI Niwa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Highly sensitive bioluminescence and fluorescence imaging system for large fields of view
用于大视场的高灵敏度生物发光和荧光成像系统
- 批准号:
520682693 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Major Research Instrumentation
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
- 批准号:
10829717 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Orthogonal split luciferases for imaging multiplexed cellular behaviors
用于多重细胞行为成像的正交分裂荧光素酶
- 批准号:
10730660 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Disease-homing light delivery by engineering bioluminescent immune cells for whole body precision photomedicine
通过工程生物发光免疫细胞进行疾病引导光传输,用于全身精准光医学
- 批准号:
10578425 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
纳米荧光素酶报告噬菌体用于快速表征下一代抗分枝杆菌药物的耐药性
- 批准号:
10593796 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Novel Bioprinted Neural Stem Cell-Embedded Hydrogel Matrices for Enhanced Treatment of Glioblastoma
新型生物打印神经干细胞嵌入水凝胶基质,用于增强胶质母细胞瘤的治疗
- 批准号:
10749330 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Project 2 - Molecular Imaging of ectopic calcification
项目 2 - 异位钙化的分子成像
- 批准号:
10628929 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
通过病毒特异性 T 细胞的原位编程使 CAR T 细胞疗法大众化
- 批准号:
10739646 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Optical platform for functional longitudinal imaging of metabolite uptake in vivo
用于体内代谢物摄取功能纵向成像的光学平台
- 批准号:
10585764 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Synergistically Target Mitochondria for Heart Failure Treatment
协同靶向线粒体治疗心力衰竭
- 批准号:
10584938 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别: